nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.067	0.126	CbGbCtD
Etonogestrel—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.063	0.119	CbGbCtD
Etonogestrel—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.063	0.119	CbGbCtD
Etonogestrel—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.057	0.107	CbGbCtD
Etonogestrel—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.057	0.107	CbGbCtD
Etonogestrel—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0492	0.0925	CbGbCtD
Etonogestrel—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0478	0.0898	CbGbCtD
Etonogestrel—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0432	0.0812	CbGbCtD
Etonogestrel—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0432	0.0812	CbGbCtD
Etonogestrel—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0414	0.0779	CbGbCtD
Etonogestrel—SHBG—semen—acquired immunodeficiency syndrome	0.0154	0.263	CbGeAlD
Etonogestrel—SHBG—blood plasma—acquired immunodeficiency syndrome	0.00559	0.0958	CbGeAlD
Etonogestrel—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.0022	0.0377	CbGeAlD
Etonogestrel—SHBG—blood—acquired immunodeficiency syndrome	0.00205	0.0351	CbGeAlD
Etonogestrel—SHBG—bone marrow—acquired immunodeficiency syndrome	0.00198	0.034	CbGeAlD
Etonogestrel—PGR—lymphoid tissue—acquired immunodeficiency syndrome	0.00196	0.0336	CbGeAlD
Etonogestrel—SHBG—vagina—acquired immunodeficiency syndrome	0.0019	0.0325	CbGeAlD
Etonogestrel—PGR—blood—acquired immunodeficiency syndrome	0.00185	0.0316	CbGeAlD
Etonogestrel—PGR—vagina—acquired immunodeficiency syndrome	0.00171	0.0293	CbGeAlD
Etonogestrel—PGR—lung—acquired immunodeficiency syndrome	0.00162	0.0277	CbGeAlD
Etonogestrel—SHBG—central nervous system—acquired immunodeficiency syndrome	0.0016	0.0274	CbGeAlD
Etonogestrel—ESR1—lymphoid tissue—acquired immunodeficiency syndrome	0.00153	0.0263	CbGeAlD
Etonogestrel—ESR1—digestive system—acquired immunodeficiency syndrome	0.00152	0.026	CbGeAlD
Etonogestrel—PGR—nervous system—acquired immunodeficiency syndrome	0.0015	0.0257	CbGeAlD
Etonogestrel—ESR1—blood—acquired immunodeficiency syndrome	0.00144	0.0247	CbGeAlD
Etonogestrel—PGR—central nervous system—acquired immunodeficiency syndrome	0.00144	0.0247	CbGeAlD
Etonogestrel—ESR1—vagina—acquired immunodeficiency syndrome	0.00134	0.0229	CbGeAlD
Etonogestrel—SHBG—brain—acquired immunodeficiency syndrome	0.00127	0.0218	CbGeAlD
Etonogestrel—ESR1—lung—acquired immunodeficiency syndrome	0.00127	0.0217	CbGeAlD
Etonogestrel—ESR1—nervous system—acquired immunodeficiency syndrome	0.00117	0.0201	CbGeAlD
Etonogestrel—PGR—brain—acquired immunodeficiency syndrome	0.00115	0.0196	CbGeAlD
Etonogestrel—ESR1—central nervous system—acquired immunodeficiency syndrome	0.00113	0.0193	CbGeAlD
Etonogestrel—PGR—lymph node—acquired immunodeficiency syndrome	0.00111	0.019	CbGeAlD
Etonogestrel—ESR1—brain—acquired immunodeficiency syndrome	0.000896	0.0153	CbGeAlD
Etonogestrel—ESR1—lymph node—acquired immunodeficiency syndrome	0.000866	0.0148	CbGeAlD
Etonogestrel—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000846	0.0145	CbGeAlD
Etonogestrel—CYP3A4—blood—acquired immunodeficiency syndrome	0.000806	0.0138	CbGeAlD
Etonogestrel—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000654	0.0112	CbGeAlD
Etonogestrel—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00063	0.0108	CbGeAlD
Etonogestrel—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000287	0.0007	CcSEcCtD
Etonogestrel—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000286	0.000699	CcSEcCtD
Etonogestrel—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.000698	CcSEcCtD
Etonogestrel—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000286	0.000698	CcSEcCtD
Etonogestrel—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.000696	CcSEcCtD
Etonogestrel—Rash—Didanosine—acquired immunodeficiency syndrome	0.000284	0.000694	CcSEcCtD
Etonogestrel—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000284	0.000694	CcSEcCtD
Etonogestrel—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000284	0.000694	CcSEcCtD
Etonogestrel—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000284	0.000694	CcSEcCtD
Etonogestrel—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000284	0.000693	CcSEcCtD
Etonogestrel—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.00069	CcSEcCtD
Etonogestrel—Headache—Didanosine—acquired immunodeficiency syndrome	0.000282	0.00069	CcSEcCtD
Etonogestrel—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000282	0.000688	CcSEcCtD
Etonogestrel—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.000687	CcSEcCtD
Etonogestrel—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000281	0.000687	CcSEcCtD
Etonogestrel—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000281	0.000686	CcSEcCtD
Etonogestrel—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.000686	CcSEcCtD
Etonogestrel—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00028	0.000684	CcSEcCtD
Etonogestrel—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.000683	CcSEcCtD
Etonogestrel—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000279	0.00068	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000278	0.000679	CcSEcCtD
Etonogestrel—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.000678	CcSEcCtD
Etonogestrel—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000278	0.000678	CcSEcCtD
Etonogestrel—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000277	0.000677	CcSEcCtD
Etonogestrel—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000277	0.000676	CcSEcCtD
Etonogestrel—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000277	0.000675	CcSEcCtD
Etonogestrel—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.000674	CcSEcCtD
Etonogestrel—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000276	0.000674	CcSEcCtD
Etonogestrel—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000276	0.000674	CcSEcCtD
Etonogestrel—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000275	0.000671	CcSEcCtD
Etonogestrel—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.000671	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.000669	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000273	0.000667	CcSEcCtD
Etonogestrel—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000273	0.000666	CcSEcCtD
Etonogestrel—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000273	0.000666	CcSEcCtD
Etonogestrel—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.000666	CcSEcCtD
Etonogestrel—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.000666	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.000665	CcSEcCtD
Etonogestrel—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.000665	CcSEcCtD
Etonogestrel—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.000664	CcSEcCtD
Etonogestrel—Pain—Indinavir—acquired immunodeficiency syndrome	0.000271	0.000661	CcSEcCtD
Etonogestrel—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000271	0.000661	CcSEcCtD
Etonogestrel—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.00066	CcSEcCtD
Etonogestrel—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00027	0.00066	CcSEcCtD
Etonogestrel—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.00066	CcSEcCtD
Etonogestrel—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.000657	CcSEcCtD
Etonogestrel—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000269	0.000657	CcSEcCtD
Etonogestrel—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000269	0.000657	CcSEcCtD
Etonogestrel—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000269	0.000656	CcSEcCtD
Etonogestrel—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000268	0.000655	CcSEcCtD
Etonogestrel—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.000655	CcSEcCtD
Etonogestrel—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000268	0.000654	CcSEcCtD
Etonogestrel—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000268	0.000654	CcSEcCtD
Etonogestrel—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000266	0.000649	CcSEcCtD
Etonogestrel—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000266	0.000648	CcSEcCtD
Etonogestrel—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000266	0.000648	CcSEcCtD
Etonogestrel—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.000646	CcSEcCtD
Etonogestrel—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.000646	CcSEcCtD
Etonogestrel—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000264	0.000644	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.000644	CcSEcCtD
Etonogestrel—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.000642	CcSEcCtD
Etonogestrel—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.000641	CcSEcCtD
Etonogestrel—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000261	0.000637	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.000636	CcSEcCtD
Etonogestrel—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.000634	CcSEcCtD
Etonogestrel—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.000634	CcSEcCtD
Etonogestrel—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00026	0.000634	CcSEcCtD
Etonogestrel—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.000633	CcSEcCtD
Etonogestrel—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000259	0.000632	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000259	0.000632	CcSEcCtD
Etonogestrel—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.000632	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00063	CcSEcCtD
Etonogestrel—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.000629	CcSEcCtD
Etonogestrel—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000258	0.000629	CcSEcCtD
Etonogestrel—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.000629	CcSEcCtD
Etonogestrel—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.000627	CcSEcCtD
Etonogestrel—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000257	0.000627	CcSEcCtD
Etonogestrel—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.000624	CcSEcCtD
Etonogestrel—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.000624	CcSEcCtD
Etonogestrel—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000256	0.000624	CcSEcCtD
Etonogestrel—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000255	0.000623	CcSEcCtD
Etonogestrel—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000255	0.000623	CcSEcCtD
Etonogestrel—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.000622	CcSEcCtD
Etonogestrel—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.000621	CcSEcCtD
Etonogestrel—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000254	0.00062	CcSEcCtD
Etonogestrel—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.000618	CcSEcCtD
Etonogestrel—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.000618	CcSEcCtD
Etonogestrel—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.000617	CcSEcCtD
Etonogestrel—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.000616	CcSEcCtD
Etonogestrel—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.000616	CcSEcCtD
Etonogestrel—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.000615	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.000614	CcSEcCtD
Etonogestrel—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000251	0.000614	CcSEcCtD
Etonogestrel—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.000611	CcSEcCtD
Etonogestrel—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00025	0.000611	CcSEcCtD
Etonogestrel—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00025	0.000611	CcSEcCtD
Etonogestrel—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.00061	CcSEcCtD
Etonogestrel—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.000609	CcSEcCtD
Etonogestrel—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000249	0.000608	CcSEcCtD
Etonogestrel—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000607	CcSEcCtD
Etonogestrel—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000248	0.000604	CcSEcCtD
Etonogestrel—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000247	0.000604	CcSEcCtD
Etonogestrel—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.000604	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000603	CcSEcCtD
Etonogestrel—Rash—Stavudine—acquired immunodeficiency syndrome	0.000247	0.000603	CcSEcCtD
Etonogestrel—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000602	CcSEcCtD
Etonogestrel—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000247	0.000602	CcSEcCtD
Etonogestrel—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.000601	CcSEcCtD
Etonogestrel—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000246	0.0006	CcSEcCtD
Etonogestrel—Headache—Stavudine—acquired immunodeficiency syndrome	0.000245	0.000599	CcSEcCtD
Etonogestrel—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000245	0.000599	CcSEcCtD
Etonogestrel—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.000597	CcSEcCtD
Etonogestrel—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.000597	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.000597	CcSEcCtD
Etonogestrel—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000244	0.000596	CcSEcCtD
Etonogestrel—Rash—Abacavir—acquired immunodeficiency syndrome	0.000243	0.000594	CcSEcCtD
Etonogestrel—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000243	0.000593	CcSEcCtD
Etonogestrel—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.000593	CcSEcCtD
Etonogestrel—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.000593	CcSEcCtD
Etonogestrel—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.000592	CcSEcCtD
Etonogestrel—Headache—Abacavir—acquired immunodeficiency syndrome	0.000242	0.00059	CcSEcCtD
Etonogestrel—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.000589	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000588	CcSEcCtD
Etonogestrel—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000241	0.000588	CcSEcCtD
Etonogestrel—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.000588	CcSEcCtD
Etonogestrel—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000584	CcSEcCtD
Etonogestrel—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000581	CcSEcCtD
Etonogestrel—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.00058	CcSEcCtD
Etonogestrel—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.00058	CcSEcCtD
Etonogestrel—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.000577	CcSEcCtD
Etonogestrel—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.000577	CcSEcCtD
Etonogestrel—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000576	CcSEcCtD
Etonogestrel—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.000575	CcSEcCtD
Etonogestrel—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.000574	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.000571	CcSEcCtD
Etonogestrel—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000233	0.000569	CcSEcCtD
Etonogestrel—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000233	0.000569	CcSEcCtD
Etonogestrel—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000568	CcSEcCtD
Etonogestrel—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000233	0.000568	CcSEcCtD
Etonogestrel—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000233	0.000568	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000566	CcSEcCtD
Etonogestrel—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000565	CcSEcCtD
Etonogestrel—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000562	CcSEcCtD
Etonogestrel—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000561	CcSEcCtD
Etonogestrel—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000229	0.000559	CcSEcCtD
Etonogestrel—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000558	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000557	CcSEcCtD
Etonogestrel—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000557	CcSEcCtD
Etonogestrel—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.000555	CcSEcCtD
Etonogestrel—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000227	0.000554	CcSEcCtD
Etonogestrel—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.000553	CcSEcCtD
Etonogestrel—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000552	CcSEcCtD
Etonogestrel—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000552	CcSEcCtD
Etonogestrel—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000552	CcSEcCtD
Etonogestrel—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000552	CcSEcCtD
Etonogestrel—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.000549	CcSEcCtD
Etonogestrel—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000547	CcSEcCtD
Etonogestrel—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000224	0.000546	CcSEcCtD
Etonogestrel—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00054	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00054	CcSEcCtD
Etonogestrel—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.000538	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.000537	CcSEcCtD
Etonogestrel—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000536	CcSEcCtD
Etonogestrel—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.000536	CcSEcCtD
Etonogestrel—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000532	CcSEcCtD
Etonogestrel—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000532	CcSEcCtD
Etonogestrel—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000531	CcSEcCtD
Etonogestrel—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000531	CcSEcCtD
Etonogestrel—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000217	0.000529	CcSEcCtD
Etonogestrel—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000216	0.000528	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000528	CcSEcCtD
Etonogestrel—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.000527	CcSEcCtD
Etonogestrel—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.000524	CcSEcCtD
Etonogestrel—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.000524	CcSEcCtD
Etonogestrel—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000523	CcSEcCtD
Etonogestrel—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000522	CcSEcCtD
Etonogestrel—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000213	0.00052	CcSEcCtD
Etonogestrel—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000516	CcSEcCtD
Etonogestrel—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000515	CcSEcCtD
Etonogestrel—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.000514	CcSEcCtD
Etonogestrel—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000513	CcSEcCtD
Etonogestrel—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000512	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000512	CcSEcCtD
Etonogestrel—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000511	CcSEcCtD
Etonogestrel—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000209	0.000511	CcSEcCtD
Etonogestrel—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00051	CcSEcCtD
Etonogestrel—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00051	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000508	CcSEcCtD
Etonogestrel—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000507	CcSEcCtD
Etonogestrel—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000507	CcSEcCtD
Etonogestrel—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.000501	CcSEcCtD
Etonogestrel—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000499	CcSEcCtD
Etonogestrel—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000494	CcSEcCtD
Etonogestrel—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000494	CcSEcCtD
Etonogestrel—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.000493	CcSEcCtD
Etonogestrel—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000491	CcSEcCtD
Etonogestrel—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000491	CcSEcCtD
Etonogestrel—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000491	CcSEcCtD
Etonogestrel—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000489	CcSEcCtD
Etonogestrel—Rash—Indinavir—acquired immunodeficiency syndrome	0.0002	0.000487	CcSEcCtD
Etonogestrel—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000487	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000485	CcSEcCtD
Etonogestrel—Headache—Indinavir—acquired immunodeficiency syndrome	0.000198	0.000484	CcSEcCtD
Etonogestrel—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000483	CcSEcCtD
Etonogestrel—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000478	CcSEcCtD
Etonogestrel—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000476	CcSEcCtD
Etonogestrel—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000471	CcSEcCtD
Etonogestrel—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000469	CcSEcCtD
Etonogestrel—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000469	CcSEcCtD
Etonogestrel—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000464	CcSEcCtD
Etonogestrel—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000463	CcSEcCtD
Etonogestrel—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000462	CcSEcCtD
Etonogestrel—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.00046	CcSEcCtD
Etonogestrel—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.00046	CcSEcCtD
Etonogestrel—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000459	CcSEcCtD
Etonogestrel—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000458	CcSEcCtD
Etonogestrel—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000457	CcSEcCtD
Etonogestrel—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000457	CcSEcCtD
Etonogestrel—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000446	CcSEcCtD
Etonogestrel—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000444	CcSEcCtD
Etonogestrel—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000442	CcSEcCtD
Etonogestrel—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.00044	CcSEcCtD
Etonogestrel—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.00044	CcSEcCtD
Etonogestrel—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.00044	CcSEcCtD
Etonogestrel—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000437	CcSEcCtD
Etonogestrel—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000437	CcSEcCtD
Etonogestrel—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000433	CcSEcCtD
Etonogestrel—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000427	CcSEcCtD
Etonogestrel—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000425	CcSEcCtD
Etonogestrel—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000425	CcSEcCtD
Etonogestrel—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000419	CcSEcCtD
Etonogestrel—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000415	CcSEcCtD
Etonogestrel—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000411	CcSEcCtD
Etonogestrel—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000411	CcSEcCtD
Etonogestrel—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000407	CcSEcCtD
Etonogestrel—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000407	CcSEcCtD
Etonogestrel—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000406	CcSEcCtD
Etonogestrel—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000405	CcSEcCtD
Etonogestrel—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000395	CcSEcCtD
Etonogestrel—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000392	CcSEcCtD
Etonogestrel—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000392	CcSEcCtD
Etonogestrel—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000392	CcSEcCtD
Etonogestrel—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000389	CcSEcCtD
Etonogestrel—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000384	CcSEcCtD
Etonogestrel—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000377	CcSEcCtD
Etonogestrel—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000374	CcSEcCtD
Etonogestrel—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000373	CcSEcCtD
Etonogestrel—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000371	CcSEcCtD
Etonogestrel—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000369	CcSEcCtD
Etonogestrel—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000352	CcSEcCtD
Etonogestrel—Norethindrone—ALB—acquired immunodeficiency syndrome	7.43e-05	0.4	CrCbGaD
Etonogestrel—Methyltestosterone—ALB—acquired immunodeficiency syndrome	7.06e-05	0.38	CrCbGaD
Etonogestrel—Testosterone—ALB—acquired immunodeficiency syndrome	4.09e-05	0.22	CrCbGaD
